Myung Hee Kim
Biographic Data
| ID | 4161590 |
|---|---|
| NAME | Myung Hee Kim |
| GIVEN NAMES | Myung Hee |
| FAMILY NAME | Kim |
| SIGNATURE | KIM M H |
| AFFILIATIONS | Yonsei University College of Medicine |
| ORCID | 0000-0003-2856-9066 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2001 |
| LATEST PUBLICATION YEAR | 2011 |
| H-INDEX | 1 |
Inhibitory Effects of 1',2'-Dihydrorotenone on Osteoclast Differentiation and Bone Resorption In Vitro and In Vivo
It is important to identify therapeutic compounds with no adverse effects for use in the chemotherapy of patients with bone-related diseases. The aim of this study was to identify a new compound that inhibits osteoclast differentiation and bone resorption. Herein, we examined the effects of 1’,2’-dihydrorotenone on osteoclast differentiation and bone resorption in vitro and in vivo. 1’,2’-dihydrorotenone inhibited receptor activator of NF-κB liga…
Development of Model System for Radiation Induced Congenital Malformations by Whole Embryo Culture
Intestinal Rotation, Luminal Obstruction and Recanalization in the Human Embryos and Fetuses
Inhibitory Effects of 1',2'-Dihydrorotenone on Osteoclast Differentiation and Bone Resorption In Vitro and In Vivo
It is important to identify therapeutic compounds with no adverse effects for use in the chemotherapy of patients with bone-related diseases. The aim of this study was to identify a new compound that inhibits osteoclast differentiation and bone resorption. Herein, we examined the effects of 1’,2’-dihydrorotenone on osteoclast differentiation and bone resorption in vitro and in vivo. 1’,2’-dihydrorotenone inhibited receptor activator of NF-κB liga…
Intestinal Rotation, Luminal Obstruction and Recanalization in the Human Embryos and Fetuses
Development of Model System for Radiation Induced Congenital Malformations by Whole Embryo Culture
Inhibitory Effects of 1',2'-Dihydrorotenone on Osteoclast Differentiation and Bone Resorption In Vitro and In Vivo
It is important to identify therapeutic compounds with no adverse effects for use in the chemotherapy of patients with bone-related diseases. The aim of this study was to identify a new compound that inhibits osteoclast differentiation and bone resorption. Herein, we examined the effects of 1’,2’-dihydrorotenone on osteoclast differentiation and bone resorption in vitro and in vivo. 1’,2’-dihydrorotenone inhibited receptor activator of NF-κB liga…
Biology (3 works) · Cell Biology (3 works) · Embryo (2 works) · Genetics (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Pregnancy (2 works) · Activator (genetics (1 work) · Anatomy (1 work) · Biochemistry (1 work)